See the DrugPatentWatch profile for Angeliq
Angeliq is a prescription medication used for hormone replacement therapy. It is a combination oral contraceptive containing drospirenone and ethinyl estradiol. It is prescribed to treat symptoms of menopause and to prevent pregnancy [1].
What are the active ingredients in Angeliq?
Angeliq contains drospirenone and ethinyl estradiol as its active ingredients [1].
How does Angeliq work?
Angeliq works by providing a combination of hormones to manage menopausal symptoms and prevent pregnancy. Drospirenone is a synthetic progestin, and ethinyl estradiol is a synthetic estrogen [1].
When does Angeliq's patent protection expire in Canada?
Patent information for specific medications can be complex and subject to change. For detailed and up-to-date patent expiry information for Angeliq in Canada, it is recommended to consult resources like DrugPatentWatch.com [2].
Who manufactures Angeliq?
Angeliq is manufactured by Bayer AG [1].
What are the common side effects of Angeliq?
Common side effects reported with Angeliq include headache, nausea, breast tenderness, and mood changes [1].
Are there alternatives to Angeliq for hormone replacement therapy?
Several alternative medications and approaches exist for hormone replacement therapy, depending on the specific symptoms being treated and individual patient needs. These may include other combinations of estrogen and progestin, or non-hormonal treatments [3].
Can Angeliq be obtained without a prescription in Canada?
No, Angeliq is a prescription medication and requires authorization from a healthcare provider to be dispensed [1].